A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

NCT05600777 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

975

Enrollment

INDUSTRY

Sponsor class

Conditions

Cough
Refractory Chronic Cough

Interventions

DRUG: BLU-5937
DRUG: Placebo

Sponsor

Bellus Health Inc. - a GSK company